Abacavir
- Strength
- 300 mg/1
- Form
- Tablet
- Class
- Human Immunodeficiency Virus Nucleoside…
Camber Pharmaceuticals, Inc.
abacavir sulfate, dolutegravir sodium, lamivudine
Listed by ViiV Healthcare Company
This is a combination product. It is not interchangeable with a single-ingredient medicine containing only one of these.
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor |
| Approval route | NDA — original brand approval |
| NDC code | 49702-231 |
| FDA application | NDA205551 |
| RxNorm concept | 1546888 |
| Package sizes listed | 1 |
| Marketed since | August 2014 |
Same active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Camber Pharmaceuticals, Inc.
Coupler LLC
AvPAK
American Health Packaging
Cipla USA Inc.
Major Pharmaceuticals
Camber Pharmaceuticals, Inc.
Abacavir Sulfate
Aurobindo Pharma Limited
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.
Please don't share card details in chat.